Immunocore Holdings IMCR
NASDAQ IMCR
$36.13 -1.44 (-3.85%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immunocore Holdings (IMCR) Other Working Capital Changes (2024 - 2026)

Immunocore Holdings (IMCR) posted Other Working Capital Changes of -$864000.0 for Q1 2026, up 66.99% sequentially from -$2.6 million in Q4 2025, and down 214.29% YoY from $756000.0 in Q1 2025.

Analysis

Immunocore Holdings (IMCR) Other Working Capital Changes (2024 - 2026) Analysis & Trends

Immunocore Holdings has reported Other Working Capital Changes for 4 years, with the latest figure at -$864000.0 in Q1 2026.

  • Quarterly Other Working Capital Changes fell 214.29% year-over-year to -$864000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.7 million (down 823.63% YoY) and the FY2025 annual result came in at -$2.1 million, down 27.0% from the prior year.
  • Other Working Capital Changes improved to -$864000.0 in Q1 2026 per IMCR's latest filing, from -$2.6 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $27.2 million in Q4 2023 and troughed at -$18.1 million in Q1 2023.
  • A 4-year average of $3.6 million and a median of $1.9 million in 2024 frame the typical range for Other Working Capital Changes.
  • The widest YoY moves for Other Working Capital Changes: up 1561.11% in 2025, down 494.77% in 2025.
  • Over 4 years, Other Working Capital Changes stood at -$8.7 million in 2023, then soared by 94.92% to -$440000.0 in 2024, then plunged by 494.77% to -$2.6 million in 2025, then jumped by 66.99% to -$864000.0 in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$864000.0, -$2.6 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Immunocore Holdings 1.85 Bn 965.54 Mn 114.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -146,000.00
Jun 30, 2026 -146,000.00
Mar 31, 2026 -146,000.00
Mar 31, 2026 -146,000.00
Dec 31, 2025 -144,000.00
Dec 31, 2025 -144,000.00
Sep 30, 2025 -146,000.00
Sep 30, 2025 -146,000.00
Jun 30, 2025 -97,000.00
Jun 30, 2025 -97,000.00
Sep 30, 2024 -1,000.00
Sep 30, 2024 -1,000.00